多柔比星心肌毒性监测及预防研究的进展 |
| |
引用本文: | 樊凌云,阮毅燕. 多柔比星心肌毒性监测及预防研究的进展[J]. 心血管康复医学杂志, 2014, 0(3): 355-358 |
| |
作者姓名: | 樊凌云 阮毅燕 |
| |
作者单位: | 广西壮族自治区妇幼保健院儿科,广西南宁530000 |
| |
摘 要: | 多柔比星(doxorubicin,DOX)属蒽醌类抗肿瘤抗生素,是目前临床应用最广泛的抗癌药之一,但对心脏有毒性作用,怎样减轻其心脏毒性,仍然是目前研究的热门问题。本文就DOX心脏毒性的监测及预防进行综述。
|
关 键 词: | 心肌 毒性作用 多柔比星 |
Research progress for monitoring and prevention of doxorubicin cardiotoxicity |
| |
Affiliation: | FAN Ling-yun, RUAN Yi- yan(Department of Pediatrics, Maternal & Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530000, China) |
| |
Abstract: | Doxorubicin (DOX)belongs to anthraquinone anti-tumor antibiotics,which is now one of most widely used anti-cancer drugs in clinic,but it possesses cardiotoxicity.How to reduce its cardiotoxicity is still a hot problem in current research.This article made an overview for monitoring and prevention of DOX cardiotoxicity. |
| |
Keywords: | Myocardium Toxic actions Doxorubicin |
本文献已被 维普 等数据库收录! |
|